Edonia raises €15m for spirulina whole-food protein, with €30m of pre-orders already signed
French microalgae startup Edonia raises €15m from SWEN Blue Ocean 2, Asterion Ventures and EIT Food, with €30m of pre-orders already signed.
Edonia, the French company turning spirulina into a whole-food protein ingredient, announced a €15 million raise on 6 October 2026. SWEN Blue Ocean 2, Asterion Ventures and EIT Food led the round, which also includes non-dilutive funding from Bpifrance under the France 2030 programme and bank financing. None of the sources reporting the deal attach a series label to it. EIT Food issued the announcement from Paris, and Tech.eu and Green Queen carried matching figures the same week.
The product is sold as Edo, a soft brown mince made from spirulina and oil using a patented process the company calls Edonization, developed with AgroParisTech. Chief executive and co-founder Hugo Valentin says the texture comes from cooking the microalgae in oil at a controlled temperature rather than from formulation: "We achieve this without using any additives: no texturising agents, no flavours." Green Queen reports the ingredient at 27 grams of protein per 100 grams, a PDCAAS score of 0.97 and 20 milligrams of bioavailable iron per 100 grams, with a carbon footprint the company puts at up to 27 times lower than meat for the same quantity of protein.
The commercial position is the unusual part. Edonia says it has around €30 million in pre-orders across roughly twenty contracts with industry buyers, signed before the dedicated production line exists. First orders have been fulfilled for Aliive, which sells ready meals through its Dietbon scheme, and for the catering group Newrest, which operates in 50 countries. Green Queen reports that Aliive recorded 40 per cent of consumers switching from meat recipes to the spirulina versions at comparable satisfaction scores.
The money goes into industrialisation and into B2B foodservice sales in Europe, Japan and the United States. Rather than build from scratch, Edonia is taking a dedicated line inside an existing shared facility in France; Green Queen reports that plant as Maison Chancerelle's site in Brittany, opening within a year, with the current pilot line in Agen. "We've proven that a whole food protein can outperform the animal on nutrition and compete on price," Valentin said. Marine Reygrobellet, partner at Asterion Ventures, pointed at the order book: "From the beginning, the Edonia team built a solid commercial pipeline even before the factory was up and running."
Why it matters for AgTech founders: the €30 million of pre-orders is doing more work in this round than the technology is. Alternative protein spent five years raising against capacity that had no buyers attached, and the write-downs that followed were not failures of fermentation or extrusion, they were failures of demand sequencing. Edonia inverted it, signing roughly twenty industrial contracts first and only then raising to build the line those contracts need, which turns a factory from a bet into a fulfilment obligation and changes what a lead investor is underwriting. Two things are worth copying. First, pick a process that is cheap to prove: cooking spirulina in oil needs no precision fermentation tanks, no novel food dossier in Europe because the input is an authorised food already, and no decade of regulatory patience, so the capital goes into customers rather than into clearance. Second, do not own the first plant. A dedicated line inside somebody else's food-grade site converts a construction programme into a tenancy, and European founders should assume that the shortest path to commercial volume runs through an incumbent manufacturer with spare capacity, not through a greenfield build. The remaining risk is ordinary and should be named: pre-orders are contracts, not revenue, and the test comes when the Brittany line has to hold specification at volume against buyers who signed on pilot samples.
Edonia raises €15m for spirulina whole-food protein, with €30m of pre-orders already signed
SWEN Blue Ocean 2, Asterion Ventures and EIT Food back the French company, which says it holds €30 million of pre-orders across about twenty contracts before its dedicated plant is running.
Edonia, the French company turning spirulina into a whole-food protein ingredient, announced a €15 million raise on 6 October 2026. SWEN Blue Ocean 2, Asterion Ventures and EIT Food led the round, which also includes non-dilutive funding from Bpifrance under the France 2030 programme and bank financing. None of the sources reporting the deal attach a series label to it. EIT Food issued the announcement from Paris, and Tech.eu and Green Queen carried matching figures the same week.
The product is sold as Edo, a soft brown mince made from spirulina and oil using a patented process the company calls Edonization, developed with AgroParisTech. Chief executive and co-founder Hugo Valentin says the texture comes from cooking the microalgae in oil at a controlled temperature rather than from formulation: "We achieve this without using any additives: no texturising agents, no flavours." Green Queen reports the ingredient at 27 grams of protein per 100 grams, a PDCAAS score of 0.97 and 20 milligrams of bioavailable iron per 100 grams, with a carbon footprint the company puts at up to 27 times lower than meat for the same quantity of protein.
The commercial position is the unusual part. Edonia says it has around €30 million in pre-orders across roughly twenty contracts with industry buyers, signed before the dedicated production line exists. First orders have been fulfilled for Aliive, which sells ready meals through its Dietbon scheme, and for the catering group Newrest, which operates in 50 countries. Green Queen reports that Aliive recorded 40 per cent of consumers switching from meat recipes to the spirulina versions at comparable satisfaction scores.
The money goes into industrialisation and into B2B foodservice sales in Europe, Japan and the United States. Rather than build from scratch, Edonia is taking a dedicated line inside an existing shared facility in France; Green Queen reports that plant as Maison Chancerelle's site in Brittany, opening within a year, with the current pilot line in Agen. "We've proven that a whole food protein can outperform the animal on nutrition and compete on price," Valentin said. Marine Reygrobellet, partner at Asterion Ventures, pointed at the order book: "From the beginning, the Edonia team built a solid commercial pipeline even before the factory was up and running."
Why it matters for AgTech founders: the €30 million of pre-orders is doing more work in this round than the technology is. Alternative protein spent five years raising against capacity that had no buyers attached, and the write-downs that followed were not failures of fermentation or extrusion, they were failures of demand sequencing. Edonia inverted it, signing roughly twenty industrial contracts first and only then raising to build the line those contracts need, which turns a factory from a bet into a fulfilment obligation and changes what a lead investor is underwriting. Two things are worth copying. First, pick a process that is cheap to prove: cooking spirulina in oil needs no precision fermentation tanks, no novel food dossier in Europe because the input is an authorised food already, and no decade of regulatory patience, so the capital goes into customers rather than into clearance. Second, do not own the first plant. A dedicated line inside somebody else's food-grade site converts a construction programme into a tenancy, and European founders should assume that the shortest path to commercial volume runs through an incumbent manufacturer with spare capacity, not through a greenfield build. The remaining risk is ordinary and should be named: pre-orders are contracts, not revenue, and the test comes when the Brittany line has to hold specification at volume against buyers who signed on pilot samples.
